DE69924979D1 - Behandlung von chronischen schmerzen - Google Patents

Behandlung von chronischen schmerzen

Info

Publication number
DE69924979D1
DE69924979D1 DE69924979T DE69924979T DE69924979D1 DE 69924979 D1 DE69924979 D1 DE 69924979D1 DE 69924979 T DE69924979 T DE 69924979T DE 69924979 T DE69924979 T DE 69924979T DE 69924979 D1 DE69924979 D1 DE 69924979D1
Authority
DE
Germany
Prior art keywords
treatment
chronic pain
chronic
metanicotine
suffering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69924979T
Other languages
English (en)
Other versions
DE69924979T2 (de
Inventor
C Eisenach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wake Forest University
Original Assignee
Wake Forest University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wake Forest University filed Critical Wake Forest University
Publication of DE69924979D1 publication Critical patent/DE69924979D1/de
Application granted granted Critical
Publication of DE69924979T2 publication Critical patent/DE69924979T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69924979T 1998-02-24 1999-02-24 Behandlung von chronischen schmerzen Expired - Lifetime DE69924979T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7579498P 1998-02-24 1998-02-24
US75794P 1998-02-24
PCT/US1999/003896 WO1999043322A1 (en) 1998-02-24 1999-02-24 Method for the treatment of pain, including chronic and female specific pain

Publications (2)

Publication Number Publication Date
DE69924979D1 true DE69924979D1 (de) 2005-06-02
DE69924979T2 DE69924979T2 (de) 2006-01-19

Family

ID=22128028

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69924979T Expired - Lifetime DE69924979T2 (de) 1998-02-24 1999-02-24 Behandlung von chronischen schmerzen

Country Status (13)

Country Link
US (1) US6248744B1 (de)
EP (1) EP1056458B1 (de)
JP (1) JP2002504512A (de)
KR (2) KR20060085258A (de)
AT (1) ATE293972T1 (de)
AU (1) AU3308099A (de)
BR (1) BR9908190A (de)
CA (1) CA2321991A1 (de)
DE (1) DE69924979T2 (de)
ES (1) ES2242405T3 (de)
MX (1) MXPA00008273A (de)
PT (1) PT1056458E (de)
WO (1) WO1999043322A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US6448276B1 (en) * 2000-05-17 2002-09-10 Inspire Pharmaceuticals, Inc. Method for treating vaginal dryness with nicotinic acetylcholine receptor agonists
EP1434576A4 (de) 2001-09-13 2006-03-29 Kenneth E Miller Verfahren zur linderung von schmerzen
CA2392486A1 (en) 2002-07-05 2002-12-08 Duchesnay Inc. Pharmaceutical dosage form bearing pregnancy-friendly indicia
ES2311756T3 (es) * 2002-12-18 2009-02-16 Algorx Administracion de la capsiacina.
EP1605956B1 (de) * 2002-12-18 2015-11-11 Centrexion Therapeutics Corporation Verabreichung von capsaicinoiden zur behandlung von arthrose
AU2004230915B2 (en) * 2003-04-08 2008-08-07 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
WO2007055928A1 (en) * 2005-11-03 2007-05-18 Targacept, Inc. 5-membered ring metanicotine analogs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212188A (en) * 1992-03-02 1993-05-18 R. J. Reynolds Tabacco Company Method for treatment of neurodegenerative diseases
US5604231A (en) * 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5663357A (en) * 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5616716A (en) * 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
US5811442A (en) * 1997-02-21 1998-09-22 Bencherif; Merouane Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow
US5861423A (en) * 1997-02-21 1999-01-19 Caldwell; William Scott Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds

Also Published As

Publication number Publication date
KR20060085258A (ko) 2006-07-26
EP1056458A4 (de) 2001-06-20
KR100703640B1 (ko) 2007-04-05
ATE293972T1 (de) 2005-05-15
MXPA00008273A (es) 2002-04-24
KR20010096465A (ko) 2001-11-07
JP2002504512A (ja) 2002-02-12
BR9908190A (pt) 2000-10-24
EP1056458B1 (de) 2005-04-27
ES2242405T3 (es) 2005-11-01
CA2321991A1 (en) 1999-09-02
EP1056458A1 (de) 2000-12-06
WO1999043322A1 (en) 1999-09-02
DE69924979T2 (de) 2006-01-19
PT1056458E (pt) 2005-08-31
US6248744B1 (en) 2001-06-19
AU3308099A (en) 1999-09-15

Similar Documents

Publication Publication Date Title
ATE207356T1 (de) Verwendung von tiagabin zur behandlung von schlafstörungen
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DK0723444T3 (da) Levobupivacain, som er egnet til behandling af kronisk smerte
DE69617729D1 (de) Verwendung von antimineralcorticoidverbindungen gegen das drogenentzugssyndrom
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
DE69924979D1 (de) Behandlung von chronischen schmerzen
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
ATE291434T1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
DE60024408D1 (de) Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen
DE60128084D1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
ATE486594T1 (de) Methode zur behandlung von herzinsuffizienz
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
ATE319443T1 (de) Prävention oder behandlung von brust-, prostata- und/oder gebärmutterhalskrebs mit n,n- dimethylglycin
NO984190L (no) FremgangsmÕte for behandling av insomnia
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами

Legal Events

Date Code Title Description
8364 No opposition during term of opposition